Form 4: Applied Therapeutics Executive Sells Shares to Cover Tax Obligations

Riccardo Perfetti, Chief Medical Officer of Applied Therapeutics, sold 86,078 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On February 6, 2025, Riccardo Perfetti, the Chief Medical Officer of Applied Therapeutics, Inc., sold 86,078 shares of the company's common stock.
• The shares were sold at a price of $0.61 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting and settlement of compensatory Restricted Stock Units.
• Following the transaction, Perfetti still beneficially owns 900,775 shares of Applied Therapeutics, Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider stock sale for tax purposes. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. This sale appears to be a standard 'sell to cover' transaction, which is a common practice to manage tax obligations related to equity compensation.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the explanation provided suggests it's a routine transaction for tax purposes.

Key Dates

Keywords

Applied Therapeutics, Riccardo Perfetti, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, APLT